Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1998
06/30/1998US5773574 Amino acid sequences for cells derives from fibronectins
06/30/1998US5773573 Polypeptide
06/30/1998US5773572 Fragments of prion proteins
06/30/1998US5773571 Peptide nucleic acids
06/30/1998US5773570 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
06/30/1998US5773569 Treatment of human diseases
06/30/1998US5773477 Combination therapy to treat osteoporosis - polyphosphonates and estrogen agonists
06/30/1998US5773468 Epoxidation; amidation; deprotecting; coupling
06/30/1998US5773455 Inhibitors of prenyl transferases
06/30/1998US5773438 Synthetic matrix metalloprotease inhibitors and use thereof
06/30/1998US5773426 Proteoglucan and antidiabetic drug thereof
06/30/1998US5773418 Fibrin monomer or a composition comprising noncrosslinked fibrin is utilized as a component of the fibrin sealant
06/30/1998US5773417 Blood substitutes
06/30/1998US5773416 Methods for restoring or enhancing reproductive function in reproductively impaired hosts
06/30/1998US5773415 Cardiovascular disorders
06/30/1998US5773414 Endothelin antagonists
06/30/1998US5773413 Method of combating mammalian neoplasias, and lytic peptides therefor
06/30/1998US5773412 Use of peptides for altering αV β3 -mediated binding
06/30/1998US5773411 Cardiovascular disorders and brain disorders and coagulants
06/30/1998US5773293 Anti-ICAM-4 antibodies and hybridomas
06/30/1998US5773292 Ablate or kill cancer cells
06/30/1998US5773280 Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
06/30/1998US5773278 Acid sphingomyelinase gene
06/30/1998US5773274 Polypeptides and dna molecules
06/30/1998US5773260 Ribozyme compositions and expression vectors
06/30/1998US5773255 Culture product
06/30/1998US5773253 MYPPPY variants of CTL A4 and uses thereof
06/30/1998US5773252 Fibroblast growth factor 15
06/30/1998US5773251 DNA clone of human tissue factor inhibitor
06/30/1998US5773250 Polynucleotides encoding a transcriptional response regulator of Streptococcus pneumoniae
06/30/1998US5773247 Recombinant anti-HIV antibody and process for preparing the same
06/30/1998US5773237 Method for determining tyrosine kinase activity
06/30/1998US5773231 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
06/30/1998US5773218 Method to identify compounds which modulate ICAM-related protein interactions
06/30/1998US5773210 Using a polypeptides
06/30/1998US5773209 Prevention of formation of oxidized polyunsaturated fatty acid, suppression of gene expression through redox sensitive pathways
06/30/1998US5773033 Autologous isolated and purified fibrinogen with biocompatible anionic or cationic chitosan polymer
06/30/1998US5773032 Long-acting injection suspensions and a process for their preparation
06/30/1998US5773019 Inner core containing an effective amount of a low solubility agent covered by a non-bioerodible polymer coating layer that is permeable to the low solubility agent
06/30/1998US5773010 Low molecular weight allergen obtained from Dermatophagoides farinae
06/30/1998US5773006 Lipsome containing IL-2
06/30/1998US5773002 Miticides
06/30/1998US5773001 Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
06/30/1998US5773000 Therapeutic treatment of clostridium difficile associated diseases
06/30/1998US5772998 Neutralization of the inhibitory effects of transfoming growth factor and hybridomas
06/30/1998US5772997 Monoclonal antibodies directed to the HER2 receptor
06/30/1998US5772996 Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
06/30/1998US5772995 Compositions and methods for enhanced tumor cell immunity in vivo
06/30/1998US5772992 For therapeutic coadministering of proteins as in hematopoietic reconstitution factors or interleukin variants
06/30/1998US5772981 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
06/30/1998US5772629 Tfpi = tissue factor pathway inhibitor
06/30/1998CA2139947C Calcium channel blocking polypeptide from agelenopsis aperta
06/30/1998CA1339936C Animal interferons
06/25/1998WO1998027230A1 Methods and compositions for polypeptide engineering
06/25/1998WO1998027215A1 Live recombinant avian vaccine, using the infectious laryngotracheitis avian virus as vector
06/25/1998WO1998027211A1 The process for the expression and production of the recombinant human beta-cis interferon
06/25/1998WO1998027210A1 Compositions and methods for stimulating pancreatic islet cell regeneration
06/25/1998WO1998027208A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
06/25/1998WO1998027206A2 POLYPEPTIDES OF THE 'BASIC-HELIX-LOOP-HELIX' bHLH FAMILY, CORRESPONDING NUCLEIC ACID SEQUENCES
06/25/1998WO1998027205A2 Secreted proteins and polynucleotides encoding them
06/25/1998WO1998027202A1 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses
06/25/1998WO1998027113A2 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5
06/25/1998WO1998027112A1 Cyclic peptide derivatives
06/25/1998WO1998027110A2 Dihydroxypropyl cysteine peptide and agent containing this peptide
06/25/1998WO1998027109A1 Cycloalkyl inhibitors of protein farnesyltransferase
06/25/1998WO1998026802A1 Non-lethal conditioning methods for the treatment of acquired immunodeficiency syndrome
06/25/1998WO1998026801A1 Agent for identifying and treating metastasizing tumours
06/25/1998WO1998026797A1 Wound healing formulations containing human plasma fibronectin
06/25/1998WO1998026796A1 Methods and compositions for treating pain
06/25/1998WO1998026795A1 Use of peptides for improving the incorporation of skin grafts
06/25/1998WO1998026794A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
06/25/1998WO1998026793A1 Synthetic antibiotics
06/25/1998WO1998026789A1 Microclysmic gel for treatment of tissue trauma and burns
06/25/1998WO1998026773A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
06/25/1998WO1998026765A1 Stabilized pharmaceutical compositions and process for the preparation thereof
06/25/1998WO1998026747A2 Superantigen based methods and compositions for treatment of diseases
06/25/1998WO1998026660A1 Cd4-mimetic ligands
06/25/1998WO1998012220A3 Novel tumor proteins
06/25/1998WO1998010068A3 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
06/25/1998WO1998006440A3 Phenotypic conversion of cells mediated by external guide sequences
06/25/1998WO1998005769A3 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
06/25/1998WO1998003552A3 A multivalent major histocompatibility complex peptide fusion protein for modulating specific t cell function
06/25/1998DE19708877C1 Monoclonal antibody specific for megakaryocytes
06/25/1998DE19654826A1 Veterinary preparation contains proteolytic enzyme
06/25/1998DE19654623A1 Medicament for treating neuro-degenerative diseases
06/25/1998DE19653036A1 Cyclopeptidderivate Cyclopeptide derivatives
06/25/1998DE19652815A1 Mittel zur Identifizierung und Therapie metastasierender Tumore Means for the identification and treatment of metastatic tumors
06/25/1998DE19651992A1 Skin cell culture medium comprising serum
06/25/1998CA2589337A1 Methods and compositions for polypeptide engineering
06/25/1998CA2280233A1 Cyclopeptide derivatives
06/25/1998CA2275454A1 Polypeptides of the "basic-helix-loop-helix" bhlh family, corresponding nucleic acid sequences
06/25/1998CA2275442A1 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5
06/25/1998CA2275213A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
06/25/1998CA2275193A1 Method of producing concentrated non-buffered solutions of fibronectin
06/25/1998CA2274807A1 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses
06/25/1998CA2274732A1 Secreted proteins and polynucleotides encoding them
06/25/1998CA2274319A1 Methods and compositions for polypeptide engineering
06/25/1998CA2272853A1 Use of peptides for improving the incorporation of skin grafts
06/25/1998CA2264692A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
06/25/1998CA2264207A1 Cycloalkyl inhibitors of protein farnesyltransferase
1 ... 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 2623 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 ... 3163